Clinical trial Recruiting at 1 site Observational Ages 18 and up

Measuring gut permeability in ICU patients with organ failure

Official title: Measurement of Intestinal Permeability in Intensive Care Patients With Single or Multiple Organ Failure

Run by Direction Centrale du Service de Santé des Armées · NCT06845865 · Data updated 2026-11-12

This study is testing how well the gut works in ICU patients with organ failure from sepsis to see if it affects their overall health and recovery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment126 (estimated)
SponsorDirection Centrale du Service de Santé des Armées
Academic / other
Locations1 site (Vincennes)
StatusRecruiting
StartedFebruary 20, 2025
Main results expectedFebruary 2029
Study endsApril 30, 2029
Registry record updatedAugust 31, 2026
Trial IDNCT06845865 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include ICU patients with single or multiple organ failure secondary to sepsis who have a functional digestive tract.

Probably not a fit

Patients with organ failure not related to sepsis or those without a functional digestive tract may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate intestinal permeability in patients with single or multiple organ failure due to sepsis in an intensive care setting. By using an enteric dyed solution, the study seeks to determine the relationship between increased intestinal permeability and systemic inflammation, which may contribute to high mortality rates associated with multivisceral failure syndrome. The study will include patients who meet specific criteria regarding their organ failure severity and digestive tract functionality. The findings could provide insights into the role of gut health in critically ill patients.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of intestinal permeability in critically ill patients, potentially reducing mortality rates.

How similar studies have gone: While studies in animal models have shown a correlation between increased intestinal permeability and mortality, this approach in human patients is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patient with single organ failure, secondary to sepsis, hospitalized in intensive care for a foreseeable duration of \> 48 hours

* SAPS2 between 20 and 40 at the sixth hour after the diagnosis of organ failure.
* Consent from the patient or their trusted person.
* Affiliation to a social security system.
* Functional digestive tract and possible feeding (per os or via a nasogastric tube whose indication was determined independently of the study's needs).

Second group of patients with multi-organ failure:

* Multi-organ failure syndrome with at least 2 organ failures, secondary to sepsis.
* SAPS2 between 60 and 80 at the sixth hour after the diagnosis of organ failure.
* Consent from the patient or their trusted person.
* Affiliation to a social security system.
* Functional digestive tract and possible feeding (conscious patient able to swallow or with a nasogastric tube whose indication was determined independently of the study's needs).

Exclusion Criteria:

* Pregnant and breastfeeding women;
* Minors;
* Persons under administrative and judicial supervision;
* Absence of a functional digestive tract (patient unable to swallow and absence of a nasogastric tube, contraindication to enteral feeding);
* Patients with gastroparesis;
* Refusal of the patient or their trusted person;
* Patient with a SAPS2 at the sixth hour after the diagnosis of organ failure \< 20 or between 40 and 60 or \> 80.

Where it's running

  • Hopital Bégin
    Vincennes, France
    Recruiting

Study contacts

  • Principal investigator: Clément DUBOST, MD, PhD — National teaching army hospital BEGIN (Hôpital National d'Instruction des Armées BEGIN)
  • Study coordinator: Michael RERA, PhD
  • Email: michael.rera@cnrs.fr
  • Phone: +33781945974

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.